Results 191 to 200 of about 127,271 (293)

Imaging Pitfalls in the Detection of Infiltrative Cardiomyopathies. [PDF]

JACC Case Rep
Carey PM, Hagan G, Bois JP.
europepmc   +1 more source

Pregnancy in women with hypertrophic cardiomyopathy

, 2012
Petronella G. Pieper, Fiona Walker
openalex   +2 more sources

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Cardiomyopathies of endocrine origin: A state-of-the-art review. [PDF]

World J Cardiol
Fuentes-Mendoza JM, Concepción-Zavaleta MJ, Morón-Siguas JC, Muñoz-Moreno JM, Pérez-Reyes AI, Martinez-Galaviz R, Aguilar-Castañeda RD, González-Godoy O, Concepción-Urteaga LA, Paz-Ibarra J.   +9 more
europepmc   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu, Gui‐Qin Liu, Ya‐Ping Peng, Li‐Ling Zhang, Xian‐Jin Wang, Liang‐Chuan Chen, Yuan‐Xi Zheng, Xue‐Jun Xiang, Rui Qiao, Xian‐He Lin   +9 more
wiley   +1 more source

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Correction: De novo and inherited variants in coding and regulatory regions in genetic cardiomyopathies. [PDF]

Hum Genomics
Vadgama N, Ameen M, Sundaram L, Gaddam S, Gifford C, Nasir J, Karakikes I, Genomics England Research Consortium.   +7 more
europepmc   +1 more source

Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy [PDF]

Daniel G. Swistel, Daniele Massera, Alexandra Stepanovic, Elizabeth Adlestein, Maria Reuter, Woon Wu, Joshua A. Scheinerman, Robert G. Nampi, Darien Paone, Bette Kim, Mark V. Sherrid   +10 more
openalex   +1 more source

Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy

, 2020
Hongyan Zhao, Ling Sun, Yeqian Zhu, Qiu-Shi Chen, Wenwu Zhu, Mohammad Bilaal Toorabally, Xinguang Chen, Fengxiang Zhang   +7 more
openalex   +1 more source

Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis. [PDF]

Biomedicines
Teresi L, Trimarchi G, Licordari R, Restelli D, Taverna G, Liotta P, Micari A, Smecca I, Dendramis G, Turturiello D, Latini AC, Falasconi G, de Gregorio C, Crea P, Dattilo G, Berruezo A, Micari A, Di Bella G.   +17 more
europepmc   +1 more source